J S Lindholt

Bispebjerg Hospital, Copenhagen University, København, Capital Region, Denmark

Are you J S Lindholt?

Claim your profile

Publications (181)610.43 Total impact

  • R Søgaard, J S Lindholt
    12/2014; 48(6):668.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intra-abdominal hypertension (IAH) often leads to abdominal compartment syndrome, which is followed by intestinal ischemia and associated with a high mortality. The diagnosis of abdominal compartment syndrome is difficult, and no valid biochemical markers are available. We conducted an experimental study on pigs to determine if D-lactate could be a useful biochemical marker of intestinal ischemia. A total of eight pigs (intervention group) underwent insufflation of carbon dioxide in the abdominal cavity to induce IAH and were compared with that of eight pigs (sham group) without IAH. Blood samples were taken from the portal and jugular veins at 0, 60, 120, 180, and 240 min after insufflation of carbon dioxide, and concentrations of D-lactate and L-lactate in the two groups were compared using an unpaired t-test. The concentrations of D-lactate were increased in portal blood after 180 min of IAH (P = 0.036) and jugular blood after 240 min of IAH (P = 0.028) in the intervention group compared with those in the sham group. A similar tendency was found for L-lactate levels after 180 min of IAH (P = 0.032 and P = 0.017 for portal and jugular blood samples, respectively). Examination of the intestines revealed both macroscopic and microscopic signs of ischemia in all but one animal in the intervention group and only in one sham-pig. Our findings suggest that D-lactate could be a useful biochemical marker of intestinal ischemia induced by IAH. Copyright © 2014 Elsevier Inc. All rights reserved.
    Journal of Surgical Research 11/2014; · 2.02 Impact Factor
  • European Journal of Vascular and Endovascular Surgery 09/2014; · 2.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To investigate whether the relative size of intraluminal thrombus (ILT) in abdominal aortic aneurysms (AAAs) is associated with AAA growth. Methods This large observational study was based on a randomised population-based screening trial. Six hundred and fifteen AAAs were diagnosed in men aged 65–74 years. The relative cross-sectional area covered by the mural thrombus was estimated by a semiautomatic method using ultrasound equipment to measure the area of the ellipses, and adapting the inner ellipse (IA) to the luminal border of the thrombus and the outer ellipse to the area inside the media border (OA). The relative thrombus area was then calculated as ((OA–IA)/OU) × 100%. Four hundred and sixteen of the patients with AAA were eligible for analysis. Results The mean size of the AAA was 40.6 mm, and the mean observation time was 1.78 years. In the group with AAAs measuring 30–34 mm, 42% had ILT, with a mean relative size of 12% of the outer area. In the group with AAAs measuring >64 mm, the presence of ILT increased to 100%, with a mean relative size of 70% of the outer area. Univariate analysis showed relative ILT size, aortic diameter, smoking history, and diastolic blood pressure were significantly positively associated with growth rate, while the presence of diabetes mellitus and peripheral arterial disease were significantly negatively associated with growth rate. The relative ILT size remained significantly positively associated with the growth rate after a multivariate linear regression adjusting for potential confounders. Conclusion These findings suggest that ILT may play a part in the progression of AAAs.
    European Journal of Vascular and Endovascular Surgery 09/2014; · 2.82 Impact Factor
  • Jes S Lindholt, Rikke Søgaard, Jesper Laustsen
    [Show abstract] [Hide abstract]
    ABSTRACT: A rapid increase in endovascular aortic repair (EVAR) procedures for treatment of asymptomatic abdominal aortic aneurysms has occurred in Denmark. However, the newest level 1A evidence suggests that unrestricted use of EVAR in patients suitable for open repair lead to lower benefit and higher total costs as compared with open surgery. Amongst cases with relative and absolute contraindications for open surgery, use of EVAR is likely to lead to more benefit, however at a relatively high cost per quality-adjusted life year (QALY). This calls for a more restrictive use.
    Ugeskrift for laeger 07/2014; 176(31).
  • Judith Nielsen, Jes S Lindholt
    Ugeskrift for laeger 06/2014; 176(11A).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Immunoglobulin E (IgE) activates mast cells (MCs). It remains unknown whether IgE also activates other inflammatory cells, and contributes to the pathogenesis of abdominal aortic aneurysms (AAAs). This study demonstrates that CD4+ T cells express IgE receptor FcεR1, at much higher levels than do CD8+ T cells. IgE induces CD4+ T-cell production of IL6 and IFN-γ, but reduces their production of IL10. FcεR1 deficiency (Fcer1a−/−) protects apolipoprotein E-deficient (Apoe−/−) mice from angiotensin-II infusion-induced AAAs and reduces plasma IL6 levels. Adoptive transfer of CD4+ T cells (but not CD8+ T cells), MCs, and macrophages from Apoe−/− mice, but not those from Apoe−/−Fcer1a−/− mice, increases AAA size and plasma IL6 in Apoe−/−Fcer1a−/− recipient mice. Biweekly intravenous administration of an anti-IgE monoclonal antibody ablated plasma IgE and reduced AAAs in Apoe−/− mice. Patients with AAAs had significantly higher plasma IgE levels than those without AAAs. This study establishes an important role of IgE in AAA pathogenesis by activating CD4+ T cells, MCs, and macrophages and supports consideration of neutralizing plasma IgE in the therapeutics of human AAAs.
    EMBO Molecular Medicine 06/2014; · 7.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Ruptured abdominal aortic aneurysm (rAAA) is associated with high mortality. Research suggests that statins may reduce abdominal aortic aneurysm (AAA) growth and improve rAAA outcomes. However, the clinical impact of statins remains uncertain in relation to both the risk and prognosis of rAAA.Methods This nationwide, population-based, combined case–control and follow-up study included all patients (aged at least 50 years) with a first-time hospital admission for rAAA and 1 : 1 matched AAA controls without rupture in Denmark from 1996 to 2008. Individual-level data on preadmission drug use, co-morbidities, socioeconomic markers, healthcare contacts and death were obtained from Danish nationwide registries.ResultsThe study included 3584 cases and 3584 matched controls. Current statin use was registered for 418 patients with rAAA (11·7 per cent) and 539 AAA controls (15·0 per cent), corresponding to an age- and sex-matched odds ratio (OR) of 0·70 (95 per cent confidence interval (c.i.) 0·60 to 0·81) for rAAA in current statin users versus never users. The decreased risk of rAAA remained after adjustment for potential confounding factors (adjusted OR 0·73, 0·61 to 0·86). The overall 30-day mortality rate from time of hospital admission among patients with rAAA was 46·1 per cent in current statin users compared with 59·3 per cent in never users (adjusted mortality rate ratio (MRR) 0·80, 95 per cent c.i. 0·68 to 0·95). Patients who had formerly used statins did not have reduced mortality (adjusted MRR 0·98, 0·78 to 1·22).Conclusion Statin use was associated with a reduced risk of rAAA and lower case fatality following rAAA. These results support current guidelines that recommend statin therapy in patients diagnosed with AAA.
    British Journal of Surgery 05/2014; · 4.84 Impact Factor
  • J S Lindholt, J Laustsen
    European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery 03/2014; · 2.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Iron deposits are observed in tissue of abdominal aortic aneurysm (AAA) patients, although the underlying mechanisms are not completely elucidated. Therefore we explored circulating markers of iron metabolism in AAA patients, and tested if they could serve as biomarkers of AAA. Increased red blood cell (RBC)-borne iron retention and transferrin, transferrin receptor and ferritin expression was observed in AAA tissue compared to control aorta (immunohistochemistry and western blot). In contrast, decreased circulating iron, transferrin, mean corpuscular haemoglobin concentration (MCHC) and haemoglobin concentration, along with circulating RBC count, were observed in AAA patients (aortic diameter >3 cm, n=114) compared to controls (aortic diameter <3 cm, n=88) (ELISA), whereas hepcidin concentrations were increased in AAA subjects (MS/MS assay). Moreover, iron, transferrin and haemoglobin levels were negatively, and hepcidin positively, correlated with aortic diameter in AAA patients. The association of low haemoglobin with AAA presence or aortic diameter was independent of specific risk factors. Moreover, MCHC negatively correlated with thrombus area in another cohort of AAA patients (aortic diameter 3-5 cm, n=357). We found that anaemia was significantly more prevalent in AAA patients (aortic diameter >5 cm, n=8,912) compared to those in patients with atherosclerotic aorto-iliac occlusive disease (n=17,737) [adjusted odds ratio=1.77 (95% confidence interval: 1.61;1.93)]. Finally, the mortality risk among AAA patients with anaemia was increased by almost 30% [adjusted hazard ratio: 1.29 (95% confidence interval: 1.16;1.44)] as compared to AAA subjects without anaemia. In conclusion, local iron retention and altered iron recycling associated to high hepcidin and low transferrin systemic concentrations could lead to reduced circulating haemoglobin levels in AAA patients. Low haemoglobin levels are independently associated to AAA presence and clinical outcome.
    Thrombosis and Haemostasis 03/2014; 112(1). · 5.76 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Background and Objectives: The search for novel risk factors of cardiovascular disease (CVD) has provided valuable clinical data concerning underlying mechanism of disease. Increasing evidence indicates a possible involvement of insulin-like growth factor-I (IGF-I) and its binding protein 2 (IGFBP-2) in the pathogenesis of CVD disorders. The aim of this study was to examine the relationship between levels of IGF-I and IGFBP-2 with all-cause and CVD mortality in a prospective study of patients with lower-extremity peripheral artery disease (PAD). Methods and material: Serum IGF-I and IGFBP-2 levels were obtained in 440 patients (257 males) with symptomatic PAD. Patients were followed for a median of 6.1 (IQ 5.1 to 7.2) years. The relationship between times to lethal outcome and baseline serum IGF-I and IFGBP-2 levels were examined by Cox proportional hazard analysis. The role of IFGBP-2 for prognosis of CVD death was assessed with c-statistic. Results: During follow-up 115 (26%) patients (48 females and 67 males) died, and 53 (12%) - from CVD related causes. Cox regression analysis revealed that an increase of 100 µg/l of baseline IFGBP-2 were significantly associated with an increased risk for CVD mortality [crude hazard ration (HR) 1.14 (95% CI (1.05-1.23), and adjusted HR 1.12 (95% CI (1.01-1.24)]. The receiver operating characteristic (ROC) analysis yielded area under curve of 0.61 (95% CI: 0.51-0.67, P=0.022). However, the model including IFGBP-2 did not show a significant improvement in accuracy of CVD death prediction (the area under ROC curve 0.73 (0.66-0.80) vs. 0.75 (0.69-0.82), P=0.696), and net reclassification improvement was 10.3% (P = 0.23). Conclusions: Increased IFGBP-2 concentration was significantly and independently associated with long-term CVD mortality in patients with lower-extremity PAD. However, risk prediction of CVD mortality did not improve by adding IFGBP-2 to a model containing conventional CVD risk factors.
    Scandinavian cardiovascular journal: SCJ 02/2014; · 1.07 Impact Factor
  • British Journal of Surgery 02/2014; 101(3):291. · 4.84 Impact Factor
  • R Søgaard, J S Lindholt
    European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery 01/2014; · 2.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Galectin-3 (Gal-3) participates in different mechanisms involved in atherothrombosis, such as inflammation, proliferation, or macrophage chemotaxis. Thus, there have been committed intensive efforts to elucidate the function of Gal-3 in cardiovascular (CV) diseases. The role of Gal-3 as a circulating biomarker has been demonstrated in patients with heart failure, but its importance as a biomarker in atherothrombosis is still unknown.
    Journal of the American Heart Association. 01/2014; 3(4).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In general, it is assumed that patient education, by increasing knowledge, may change behavior and lifestyle and promote health. In this context, it is a surprise that knowledge and awareness about blood pressure and hypertension among elderly people is poor. We hypothesized that knowledge about blood pressure and hypertension would be better among individuals with self-reported hypertension compared with subjects without self-reported hypertension. We mailed a questionnaire to a random sample of 1,000 subjects living in the municipality of Silkeborg, Denmark. The study sample was drawn from the Central Person Registry. The response rate was 72%. Of these, 43% of responders had self-reported hypertension. The people with self-reported hypertension were older, less educated, had higher self-reported blood cholesterol levels, had higher body weight, and more often had a family history of hypertension. More than 80% reported that overweight and obesity increases blood pressure. More than 60% reported that untreated hypertension may cause heart disease or stroke. More than half of the responders did not know their blood pressure, and only 21% knew that hypertension can occur without symptoms. Knowledge about hypertension was independent of self-reported hypertension status, but awareness about blood pressure was most prominent among those with self-reported hypertension. General knowledge about blood pressure and hypertension was reasonable, but there is still room for improvement in elderly people's knowledge and awareness of blood pressure.
    Clinical Epidemiology 01/2014; 6:81-7.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Previous studies have reported a higher prevalence of inguinal hernia in patients with abdominal aortic aneurysm (AAA). The aim of this study was to explore the association between inguinal hernia and AAA in a large population-based cohort of men who had screening for AAA. A total of 18 331 men aged 65-76 years had ultrasound screening for AAA in the Central Region of Denmark from 2008 to 2010. The Danish National Patient Registry was interrogated, and screened men registered with an inguinal hernia from 1977 to 2011 were identified. The association between inguinal hernia and AAA was assessed by multiple logistic regression analysis. The prevalence of AAA was 3.3 per cent (601 of 18 331). A total of 2936 (16.0 per cent) of the 18 331 patients were registered with a diagnosis of inguinal hernia or hernia repair. Inguinal hernia was not associated with AAA: crude odds ratio (OR) 0.86 (95 per cent confidence interval 0.68 to 1.09) and adjusted OR 0.94 (0.75 to 1.20). In contrast to smaller patient-based studies, this large population-based study found no association between inguinal hernia and AAA.
    British Journal of Surgery 10/2013; 100(11):1478-82. · 4.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: -Abdominal aortic aneurysm (AAA) is a common cardiovascular disease among older people and demonstrates significant heritability. In contrast to similar complex diseases, relatively few genetic associations with AAA have been confirmed. We reanalysed our genome-wide study and carried through to replication suggestive discovery associations at a lower level of significance. -A genome-wide association study was conducted using 1,830 cases from the UK, New Zealand and Australia with infra-renal aorta diameter ≥30mm or ruptured AAA and 5,435 unscreened controls from the 1958 Birth Cohort and National Blood Service cohort from the Wellcome Trust Case Control Consortium. Eight suggestive associations with P<1x10(-4) were carried through to in silico replication in 1,292 AAA cases and 30,503 controls. One SNP associated with P<0.05 after Bonferroni correction in the in silico study underwent further replication (706 AAA cases and 1,063 controls from the UK, 507 AAA cases and 199 controls from Denmark and 885 AAA cases and 1,000 controls from New Zealand). Low density lipoprotein receptor (LDLR) rs6511720 A, was significantly associated overall and in three of five individual replication studies. The full study showed an association that reached genome-wide significance (odds ratio 0.76; 95% confidence interval 0.70 to 0.83; P=2.08x10(-10)). -LDLR rs6511720 is associated with abdominal aortic aneurysm. This finding is consistent with established effects of this variant on coronary artery disease. Shared aetiological pathways with other cardiovascular diseases may present novel opportunities for preventative and therapeutic strategies for AAA.
    Circulation Cardiovascular Genetics 09/2013; · 6.73 Impact Factor
  • Jes S Lindholt, Anders Green, Rikke Søgaard
    [Show abstract] [Hide abstract]
    ABSTRACT: In Denmark 2-3% of men aged 65 years or more die from abdominal aortic aneurysms (AAA). The lethality of ruptured AAA is 75%, while the risk of preventive surgery is 2-3%. Ultrasonographic screening for AAA is fast, safe and reliable. Randomized trials show that screening halves the mortality from AAA, and reduces total mortality by 2%. The latest health economic study concludes that it is highly cost-effective to screen 65-year-old Danish men, as a quality-adjusted life year can be gained for about 5,100 DKK (555 GBP). This is less than one tenth of the recently approved Danish colorectal cancer-screening programme.
    Ugeskrift for laeger 09/2013; 175(38):2170-2174.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cathepsin L (CatL), cathepsin K (CatK), and cathepsin V (CatV) are potent elastases implicated in human arterial wall remodeling. Whether plasma levels of these cathepsins are altered in patients with abdominal aortic aneurysms (AAAs) remains unknown. Plasma samples were collected from 476 male AAA patients and 200 age-matched male controls to determine CatL, CatK, and CatV levels by ELISA. Student's t-test demonstrated significantly higher plasma CatL levels in AAA patients than in controls (P < 0.0001), whereas CatK and CatV levels were lower in AAA patients than in controls (P = 0.052, P = 0.025). ROC curve analysis confirmed higher plasma CatL levels in AAA patients than in controls (P < 0.001). As potential confounders, current smoking and use of angiotensin-converting enzyme (ACE) inhibitors, aspirin, clopidogrel, and statins associated with significantly increased plasma CatL. Pearson's correlation test demonstrated that plasma CatL associated positively with CatS (r = 0.43, P < 0.0001), body-mass index (BMI) (r = 0.07, P = 0.047) and maximal aortic diameter (r = 0.29, P < 0.001), and negatively with lowest measured ankle-brachial index (ABI) (r = -0.22, P < 0.001). Plasma CatL remained associated positively with CatS (r = 0.43, P < 0.0001) and aortic diameter (r = 0.212, P < 0.001) and negatively with ABI (r = -0.10, P = 0.011) after adjusting for the aforementioned potential confounders in a partial correlation analysis. Multivariate logistic regression analysis indicated that plasma CatL was a risk factor of AAA before (odds ratio [OR] = 3.04, P < 0.001) and after (OR = 2.42, P < 0.001) the same confounder adjustment. Correlation of plasma CatL levels with aortic diameter and the lowest ABI suggest that this cysteinyl protease plays a detrimental role in the pathogenesis of human peripheral arterial diseases and AAAs.
    Atherosclerosis 09/2013; 230(1):100-5. · 3.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: To identify proteins related to intraluminal thrombus biological activities that could help to find novel pathological mechanisms and therapeutic targets for human abdominal aortic aneurysm (AAA). APPROACH AND RESULTS: Tissue-conditioned media from patients with AAA were analyzed by a mass spectrometry-based strategy using liquid chromatography coupled to tandem mass spectrometry. Global pathway analysis by Ingenuity software highlighted the presence of several circulating proteins, among them were proteins from the complement system. Complement C3 concentration and activation were assessed in plasma from AAA patients (small AAA, AAA diameter=3-5 cm and large AAA, AAA diameter >5 cm), showing decreased C3 levels and activation in large AAA patients. No association of a combination of single-nucleotide polymorphisms in complement genes between large and small AAA patients was observed. Intense extracellular C3 inmunostaining, along with C9, was observed in AAA thrombus. Analysis of C3 in AAA tissue homogenates and tissue-conditioned media showed increased levels of C3 in AAA thrombus, as well as proteolytic fragments (C3a/C3c/C3dg), suggesting its local deposition and activation. Finally, the functional role of local complement activation in polymorphonuclear (PMN) cell activation was tested, showing that C3 blockade by anti-C3 antibody was able to decrease thrombus-induced neutrophil chemotaxis and reactive oxygen species production. CONCLUSIONS: A decrease of systemic C3 concentration and activity in the later stages of AAA associated with local complement retention, consumption, and proteolysis in the thrombus could induce PMN chemotaxis and activation, playing a detrimental role in AAA progression.
    Arteriosclerosis Thrombosis and Vascular Biology 05/2013; · 6.34 Impact Factor

Publication Stats

3k Citations
610.43 Total Impact Points

Institutions

  • 2013–2014
    • Bispebjerg Hospital, Copenhagen University
      • Department of Surgery
      København, Capital Region, Denmark
    • Harvard Medical School
      • Department of Medicine
      Boston, MA, United States
  • 2002–2014
    • Odense University Hospital
      • Department of Thoracic, Cardiac and Vascular Surgery - T
      Odense, South Denmark, Denmark
  • 1999–2014
    • Regionspsykiatrien Viborg-Skive
      Viborg, Central Jutland, Denmark
  • 2011–2013
    • University of Southern Denmark
      • • Institute of Public Health
      • • Centre for Applied Health Services Research (CAST)
      Kolding, South Denmark, Denmark
  • 1999–2013
    • Aarhus University Hospital
      • • Department of Clinical Pharmacology
      • • Department of Clinical Biochemistry
      • • Department of Cardiothoracic and Vascular Surgery
      Aarhus, Central Jutland, Denmark
  • 2012
    • deCODE genetics, Inc.
      Reikiavik, Capital Region, Iceland
    • Wuhan Union Hospital
      Wu-han-shih, Hubei, China
  • 2009–2012
    • Brigham and Women's Hospital
      • Department of Medicine
      Cambridge, MA, United States
  • 2001–2012
    • Aarhus University
      • Department of Medical Biochemistry
      Aarhus, Central Jutland, Denmark
  • 2010
    • CSU Mentor
      Long Beach, California, United States
  • 2009–2010
    • Herning Hospital
      Herning, Central Jutland, Denmark
  • 2008–2009
    • Regionshospitalet Viborg
      Skive, Central Jutland, Denmark
  • 2003
    • The Quality of Life Research Center
      København, Capital Region, Denmark
    • University of California, San Francisco
      • Division of Hospital Medicine
      San Francisco, CA, United States
    • University of Copenhagen
      • Department of Vascular Surgery
      Copenhagen, Capital Region, Denmark